Rock Springs Capital Management LP Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$2.6B
Holdings
147
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (147 positions)
| Stock | Value |
|---|---|
UNHUNITEDHEALTH GROUP INC | $139.2M |
MDGLMADRIGAL PHARMACEUTICALS INC | $95.7M |
ISRGINTUITIVE SURGICAL INC | $67.9M |
NBIXNEUROCRINE BIOSCIENCES INC | $61.9M |
—GW PHARMACEUTICALS PLC | $61.4M |
ALXNALEXION PHARMACEUTICALS INC | $61.1M |
ABBVABBVIE INC | $55.6M |
WCGEURWELLCARE HEALTH PLANS INC | $54.9M |
MOHMOLINA HEALTHCARE INC | $53.4M |
ACHCACADIA HEALTHCARE COMPANY IN | $51.3M |
—LOXO ONCOLOGY INC | $50.3M |
—SPARK THERAPEUTICS INC | $45.0M |
HCAHCA HEALTHCARE INC | $44.1M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $39.4M |
SRPTSAREPTA THERAPEUTICS INC | $39.3M |
IRTCIRHYTHM TECHNOLOGIES INC | $38.9M |
PCRXPACIRA PHARMACEUTICALS INC | $38.4M |
—RADIUS HEALTH INC | $33.2M |
ONCBEIGENE LTD | $33.1M |
PENPENUMBRA INC | $32.7M |
VRTXVERTEX PHARMACEUTICALS INC | $32.4M |
EHCENCOMPASS HEALTH CORP | $30.5M |
SYKSTRYKER CORP | $30.1M |
CELGCELGENE CORP | $28.6M |
DVADAVITA INC | $28.4M |
PBYIPUMA BIOTECHNOLOGY INC | $28.1M |
—TESARO INC | $27.8M |
AXGNAXOGEN INC | $27.4M |
PRAHPRA HEALTH SCIENCES INC | $26.9M |
—WRIGHT MED GROUP N V | $26.0M |
GILDGILEAD SCIENCES INC | $25.9M |
—MEDICINES CO | $25.3M |
TFXTELEFLEX INC | $24.8M |
—ALDER BIOPHARMACEUTICALS INC | $24.7M |
EWEDWARDS LIFESCIENCES CORP | $24.0M |
EXASEXACT SCIENCES CORP | $22.7M |
AFWALIGN TECHNOLOGY INC | $22.6M |
INGNINOGEN INC | $22.2M |
BAXBAXTER INTL INC | $21.9M |
HRTXHERON THERAPEUTICS INC | $20.4M |
TMOTHERMO FISHER SCIENTIFIC INC | $19.9M |
INCYINCYTE CORP | $19.8M |
IM8NINSMED INC | $19.5M |
NUVAGBPNUVASIVE INC | $19.4M |
FGENEURFIBROGEN INC | $19.2M |
ABGAMERISOURCEBERGEN CORP | $18.8M |
ZBHZIMMER BIOMET HLDGS INC | $17.9M |
—MERSANA THERAPEUTICS INC | $17.9M |
ASMBASSEMBLY BIOSCIENCES INC | $17.6M |
ACRSACLARIS THERAPEUTICS INC | $17.1M |
ALNYALNYLAM PHARMACEUTICALS INC | $17.1M |
GLPGGALAPAGOS NV | $17.1M |
—OBSEVA SA | $17.0M |
JAZZJAZZ PHARMACEUTICALS PLC | $16.9M |
—EPIZYME INC | $16.8M |
—AUDENTES THERAPEUTICS INC | $16.8M |
ARNAEURARENA PHARMACEUTICALS INC | $16.4M |
ASNDASCENDIS PHARMA A S | $16.2M |
HOLXHOLOGIC INC | $15.9M |
WSTWEST PHARMACEUTICAL SVSC INC | $15.9M |
—BIOHAVEN PHARMACTL HLDG CO L | $15.7M |
IDXXIDEXX LABS INC | $15.7M |
AM6AMICUS THERAPEUTICS INC | $15.6M |
BIIBBIOGEN INC | $15.4M |
RAREULTRAGENYX PHARMACEUTICAL IN | $15.4M |
—INTERSECT ENT INC | $15.4M |
TBPHTHERAVANCE BIOPHARMA INC | $14.8M |
GTHXEURG1 THERAPEUTICS INC | $13.0M |
EX9EXELIXIS INC | $12.8M |
—TRANSLATE BIO INC | $12.8M |
2L9BLUEPRINT MEDICINES CORP | $12.6M |
AMRNAMARIN CORP PLC | $12.4M |
—PORTOLA PHARMACEUTICALS INC | $12.2M |
—IMMUNOMEDICS INC | $11.8M |
MRTXEURMIRATI THERAPEUTICS INC | $11.8M |
BMRNBIOMARIN PHARMACEUTICAL INC | $11.8M |
CLVSEURCLOVIS ONCOLOGY INC | $11.6M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $11.2M |
—RETROPHIN INC | $10.9M |
ARGXARGENX SE | $10.7M |
ANABANAPTYSBIO INC | $10.7M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $10.4M |
NVTA1EURINVITAE CORP | $10.3M |
AG8AGILENT TECHNOLOGIES INC | $10.1M |
—ZOGENIX INC | $10.0M |
CHRSCOHERUS BIOSCIENCES INC | $9.7M |
FIXXEURHOMOLOGY MEDICINES INC | $9.6M |
—FIVE PRIME THERAPEUTICS INC | $9.4M |
ARDXARDELYX INC | $9.3M |
—ENDOCYTE INC | $9.3M |
—MOMENTA PHARMACEUTICALS INC | $9.3M |
—RTI SURGICAL INC | $9.0M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $8.9M |
—ODONATE THERAPEUTICS INC | $8.8M |
—GLOBAL CORD BLOOD CORPORATIO | $8.4M |
—APTINYX INC | $8.2M |
CBAYUSDCYMABAY THERAPEUTICS INC | $7.8M |
SPROSPERO THERAPEUTICS INC | $7.7M |
SG7SAGE THERAPEUTICS INC | $7.7M |
—RA PHARMACEUTICALS INC | $7.5M |
Page 1 of 2Next